His main research concerns Stent, Internal medicine, Cardiology, Radiology and Intravascular ultrasound. The various areas that Hector M. Garcia-Garcia examines in his Stent study include Everolimus and Myocardial infarction. Hector M. Garcia-Garcia interconnects Cause of death and Hazard ratio, Confidence interval in the investigation of issues within Cardiology.
His biological study deals with issues like Unstable angina, which deal with fields such as Stent restenosis. His studies deal with areas such as Thin-cap fibroatheroma, Fibrous cap, Angiography, Atheroma and Vascular disease as well as Intravascular ultrasound. His Optical coherence tomography study incorporates themes from Lumen and Nuclear medicine.
His primary areas of investigation include Internal medicine, Cardiology, Radiology, Intravascular ultrasound and Coronary artery disease. His work in the fields of Artery, Coronary atherosclerosis and Mace overlaps with other areas such as In patient. As a part of the same scientific study, Hector M. Garcia-Garcia usually deals with the Radiology, concentrating on Everolimus and frequently concerns with Bioresorbable vascular scaffold and Cohort.
His Intravascular ultrasound research is multidisciplinary, incorporating elements of Vulnerable plaque, Pathology, Ultrasound, Angiography and Lumen. The study incorporates disciplines such as Predictive value of tests, Fractional flow reserve, Atheroma, Hazard ratio and Prospective cohort study in addition to Coronary artery disease. Surgery covers he research in Stent.
Hector M. Garcia-Garcia mainly focuses on Internal medicine, Cardiology, Coronary artery disease, Intravascular ultrasound and Conventional PCI. His study in the field of Percutaneous coronary intervention, Revascularization, Meta-analysis and Coronary angiography is also linked to topics like In patient. His research brings together the fields of Stent and Cardiology.
His work deals with themes such as Lumen and Balloon, which intersect with Stent. Confidence interval, Odds ratio and Univariate analysis is closely connected to Atheroma in his research, which is encompassed under the umbrella topic of Coronary artery disease. His Intravascular ultrasound study introduces a deeper knowledge of Radiology.
His primary scientific interests are in Internal medicine, Cardiology, Artery, Coronary artery disease and Stent. His work on Acute coronary syndrome, Blood flow, Predictive value of tests and Thrombus as part of general Internal medicine research is frequently linked to In patient, thereby connecting diverse disciplines of science. His research in Cardiology intersects with topics in Cardiovascular research and Disease.
His study in Coronary artery disease is interdisciplinary in nature, drawing from both Intravascular ultrasound, Coronary arteries and Percutaneous coronary intervention. His Intravascular ultrasound research integrates issues from Conventional PCI and Coronary atherosclerosis. His Stent study deals with the bigger picture of Surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
Patrick W Serruys;John A Ormiston;Yoshinobu Onuma;Evelyn Regar.
The Lancet (2009)
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
John A Ormiston;Patrick W Serruys;Evelyn Regar;Dariusz Dudek.
The Lancet (2008)
Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis: 12-Month Clinical and Imaging Outcomes
Patrick W. Serruys;Yoshinobu Onuma;Dariusz Dudek;Pieter C. Smits.
Journal of the American College of Cardiology (2010)
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial
Patrick W Serruys;Bernard Chevalier;Dariusz Dudek;Angel Cequier.
The Lancet (2015)
Effects of the Direct Lipoprotein-Associated Phospholipase A 2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque
Patrick W. Serruys;Héctor M. García-García;Pawel Buszman;Paul Erne.
In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis.
Gastón A. Rodriguez-Granillo;Héctor M. García-García;Eugène P. Mc Fadden;Marco Valgimigli.
Journal of the American College of Cardiology (2005)
Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial.
Yoshinobu Onuma;Patrick W. Serruys;Laura E.L. Perkins;Takayuki Okamura.
Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery StenosisClinical Perspective
Patrick W. Serruys;Yoshinobu Onuma;John A. Ormiston;Bernard de Bruyne.
From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?
Patrick W Serruys;Hector M Garcia-Garcia;Yoshinobu Onuma.
European Heart Journal (2012)
Feasibility of combined use of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for detecting thin-cap fibroatheroma
Takahiro Sawada;Junya Shite;Hector M. Garcia-Garcia;Toshiro Shinke.
European Heart Journal (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: